Augmentation of host antitumor immunity by low doses of cyclophosphamide and mafosfamide in two animal tumor models View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1989-03

AUTHORS

Thomas Reissmann, Rainer Voegeli, Jörg Pohl, Peter Hilgard

ABSTRACT

By cloning in vitro we have obtained two sublines of the L5222 rat leukemia, one with high (L5222-S) and the other with low (L5222-R) in vivo sensitivities to non-toxic doses of mafosfamide, a stabilized derivative of 4-hydroxy-cyclophosphamide. This sensitivity in vivo was not related to the cytotoxic activity of the drug in vitro. Treatment of rats bearing the L5222-S and of mice transplanted with the MOPC-315 plasmocytoma with low doses of mafosfamide or cyclophosphamide resulted in a high percentage of surviving animals, which were resistant to a subsequent tumor challenge. Viable leukemic cells were needed to establish antitumor immunity, since it was not possible to induce resistance by injection of mitomycin-C-treated, non-viable L5222 cells. The adoptive transfer of spleen cells from animals immune against the L5222-S and the MOPC-315 resulted in resistance of the syngeneic recipients against a rechallenge with tumor cells, provided that the animals were treated with an immunosuppressive dose (100 mg/kg) of cyclophosphamide prior to the spleen cell implantation. In nude mice treatment of the L5222 with low doses of mafosfamide also resulted in surviving animals, however resistance to a second tumor challenge occurred only sporadically. The data presented confirm that therapy with cyclophosphamide or mafosfamide enhances host antitumor immunity but, contrary to previous reports, it could be demonstrated that successful tumor rejection was independent of T cells. More... »

PAGES

179-184

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf00204986

DOI

http://dx.doi.org/10.1007/bf00204986

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1025873521

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/2924329


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adjuvants, Immunologic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antigens, Neoplasm", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Clone Cells", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclophosphamide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Administration Schedule", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunity, Innate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunization, Passive", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukemia, Experimental", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice, Inbred BALB C", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice, Nude", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats, Inbred Strains", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Department of Experimental Cancer Research, Asta Pharma AG, P. O. Box 14 01 29, D-4800, Bielefeld 14, FRG"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Reissmann", 
        "givenName": "Thomas", 
        "id": "sg:person.01340535776.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340535776.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Experimental Cancer Research, Asta Pharma AG, P. O. Box 14 01 29, D-4800, Bielefeld 14, FRG"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Voegeli", 
        "givenName": "Rainer", 
        "id": "sg:person.0633453775.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0633453775.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Experimental Cancer Research, Asta Pharma AG, P. O. Box 14 01 29, D-4800, Bielefeld 14, FRG"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pohl", 
        "givenName": "J\u00f6rg", 
        "id": "sg:person.0750105001.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750105001.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Experimental Cancer Research, Asta Pharma AG, P. O. Box 14 01 29, D-4800, Bielefeld 14, FRG"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hilgard", 
        "givenName": "Peter", 
        "id": "sg:person.01023655171.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023655171.21"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf01631649", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000151847", 
          "https://doi.org/10.1007/bf01631649"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0065-2776(08)60685-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005456489"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0192-0561(85)90016-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009463786"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0192-0561(85)90016-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009463786"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1084/jem.155.1.276", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012689937"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0065-230x(08)60846-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022578868"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0192-0561(86)90098-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026508026"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0192-0561(86)90098-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026508026"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00205685", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031449860", 
          "https://doi.org/10.1007/bf00205685"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00205685", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031449860", 
          "https://doi.org/10.1007/bf00205685"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/271663a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041761092", 
          "https://doi.org/10.1038/271663a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00205549", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046560457", 
          "https://doi.org/10.1007/bf00205549"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00205549", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046560457", 
          "https://doi.org/10.1007/bf00205549"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/262077a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053098476", 
          "https://doi.org/10.1038/262077a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00199832", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053466732", 
          "https://doi.org/10.1007/bf00199832"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00199832", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053466732", 
          "https://doi.org/10.1007/bf00199832"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0022-1759(83)90303-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053705634"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0022-1759(83)90303-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053705634"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/18.6.769", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1075788095"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079465053", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079745935", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/76.4.745", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079760047"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/77.6.1255", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079781898"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079848326", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079909305", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1080245159", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1081599010", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1081632263", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082078324", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082165067", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082270364", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1989-03", 
    "datePublishedReg": "1989-03-01", 
    "description": "By cloning in vitro we have obtained two sublines of the L5222 rat leukemia, one with high (L5222-S) and the other with low (L5222-R) in vivo sensitivities to non-toxic doses of mafosfamide, a stabilized derivative of 4-hydroxy-cyclophosphamide. This sensitivity in vivo was not related to the cytotoxic activity of the drug in vitro. Treatment of rats bearing the L5222-S and of mice transplanted with the MOPC-315 plasmocytoma with low doses of mafosfamide or cyclophosphamide resulted in a high percentage of surviving animals, which were resistant to a subsequent tumor challenge. Viable leukemic cells were needed to establish antitumor immunity, since it was not possible to induce resistance by injection of mitomycin-C-treated, non-viable L5222 cells. The adoptive transfer of spleen cells from animals immune against the L5222-S and the MOPC-315 resulted in resistance of the syngeneic recipients against a rechallenge with tumor cells, provided that the animals were treated with an immunosuppressive dose (100 mg/kg) of cyclophosphamide prior to the spleen cell implantation. In nude mice treatment of the L5222 with low doses of mafosfamide also resulted in surviving animals, however resistance to a second tumor challenge occurred only sporadically. The data presented confirm that therapy with cyclophosphamide or mafosfamide enhances host antitumor immunity but, contrary to previous reports, it could be demonstrated that successful tumor rejection was independent of T cells.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/bf00204986", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1096240", 
        "issn": [
          "0340-7004", 
          "1432-0851"
        ], 
        "name": "Cancer Immunology, Immunotherapy", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "28"
      }
    ], 
    "name": "Augmentation of host antitumor immunity by low doses of cyclophosphamide and mafosfamide in two animal tumor models", 
    "pagination": "179-184", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "7b439e730321861869fefaaf8d770228eaa46844f7b7a07bb1718c1229821cb7"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "2924329"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8605732"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf00204986"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1025873521"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf00204986", 
      "https://app.dimensions.ai/details/publication/pub.1025873521"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T14:00", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000371_0000000371/records_130829_00000002.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2FBF00204986"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf00204986'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf00204986'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf00204986'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf00204986'


 

This table displays all metadata directly associated to this object as RDF triples.

234 TRIPLES      21 PREDICATES      71 URIs      38 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf00204986 schema:about N3eaebb9ab3c74ace93996a478e03030f
2 N48d9ca0ffd7549e5bac3dc17e98dceaa
3 N53f2cd6aecdf490886fe7a7d00e90290
4 N58234785e4d548a98d76a8749910389a
5 N5cfad2edadc94dca92292e170fa24469
6 N66d99ab536154b649b23c8baa0857fef
7 N72823be6efaf46bb9350166ddc02d7e6
8 N86b38f0618334fef8652fde06c1d9623
9 N8b58ed1d02574eb49952fa1616ecedd2
10 N8fdedbb5b45c4c5db09c8c85f15b65ab
11 Na25d9468dc8d4fa4aed0570ca6d9a975
12 Na413d4831e1a4cf9826616cd4860f16b
13 Nc193b22832f44093b30dfe972d2f58ad
14 Nc9fa4ce529064e1d9d7beb2bd085e039
15 Nd96152414a004be1b20a56706f6cecb7
16 Nf18f853334fc4f558a691a866754e39d
17 Nff365029f1de431dad39696ac64524b8
18 anzsrc-for:11
19 anzsrc-for:1107
20 schema:author N83d31261c3134ce7a9ca077f1e24793e
21 schema:citation sg:pub.10.1007/bf00199832
22 sg:pub.10.1007/bf00205549
23 sg:pub.10.1007/bf00205685
24 sg:pub.10.1007/bf01631649
25 sg:pub.10.1038/262077a0
26 sg:pub.10.1038/271663a0
27 https://app.dimensions.ai/details/publication/pub.1079465053
28 https://app.dimensions.ai/details/publication/pub.1079745935
29 https://app.dimensions.ai/details/publication/pub.1079848326
30 https://app.dimensions.ai/details/publication/pub.1079909305
31 https://app.dimensions.ai/details/publication/pub.1080245159
32 https://app.dimensions.ai/details/publication/pub.1081599010
33 https://app.dimensions.ai/details/publication/pub.1081632263
34 https://app.dimensions.ai/details/publication/pub.1082078324
35 https://app.dimensions.ai/details/publication/pub.1082165067
36 https://app.dimensions.ai/details/publication/pub.1082270364
37 https://doi.org/10.1016/0022-1759(83)90303-4
38 https://doi.org/10.1016/0192-0561(85)90016-5
39 https://doi.org/10.1016/0192-0561(86)90098-6
40 https://doi.org/10.1016/s0065-230x(08)60846-5
41 https://doi.org/10.1016/s0065-2776(08)60685-9
42 https://doi.org/10.1084/jem.155.1.276
43 https://doi.org/10.1093/jnci/18.6.769
44 https://doi.org/10.1093/jnci/76.4.745
45 https://doi.org/10.1093/jnci/77.6.1255
46 schema:datePublished 1989-03
47 schema:datePublishedReg 1989-03-01
48 schema:description By cloning in vitro we have obtained two sublines of the L5222 rat leukemia, one with high (L5222-S) and the other with low (L5222-R) in vivo sensitivities to non-toxic doses of mafosfamide, a stabilized derivative of 4-hydroxy-cyclophosphamide. This sensitivity in vivo was not related to the cytotoxic activity of the drug in vitro. Treatment of rats bearing the L5222-S and of mice transplanted with the MOPC-315 plasmocytoma with low doses of mafosfamide or cyclophosphamide resulted in a high percentage of surviving animals, which were resistant to a subsequent tumor challenge. Viable leukemic cells were needed to establish antitumor immunity, since it was not possible to induce resistance by injection of mitomycin-C-treated, non-viable L5222 cells. The adoptive transfer of spleen cells from animals immune against the L5222-S and the MOPC-315 resulted in resistance of the syngeneic recipients against a rechallenge with tumor cells, provided that the animals were treated with an immunosuppressive dose (100 mg/kg) of cyclophosphamide prior to the spleen cell implantation. In nude mice treatment of the L5222 with low doses of mafosfamide also resulted in surviving animals, however resistance to a second tumor challenge occurred only sporadically. The data presented confirm that therapy with cyclophosphamide or mafosfamide enhances host antitumor immunity but, contrary to previous reports, it could be demonstrated that successful tumor rejection was independent of T cells.
49 schema:genre research_article
50 schema:inLanguage en
51 schema:isAccessibleForFree false
52 schema:isPartOf Nbdf7fb01b96c48e2854d10a9ba56fdf4
53 Neb4f749381374e3fad083957ca96ec1e
54 sg:journal.1096240
55 schema:name Augmentation of host antitumor immunity by low doses of cyclophosphamide and mafosfamide in two animal tumor models
56 schema:pagination 179-184
57 schema:productId N1384a9a625554b6ea4b197ca06cf6c88
58 N166bd9b7a2364c4fb8e4d7e1b015f9ae
59 N3410a323bab14d1ebc9809362fc19ff7
60 N6a8f8f0074734b3e9078e76206d9f724
61 N8e719ca41bbf4c949b908ac7379d37d7
62 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025873521
63 https://doi.org/10.1007/bf00204986
64 schema:sdDatePublished 2019-04-11T14:00
65 schema:sdLicense https://scigraph.springernature.com/explorer/license/
66 schema:sdPublisher Ndfad057bf444412ab29ea54426d9b8ae
67 schema:url http://link.springer.com/10.1007%2FBF00204986
68 sgo:license sg:explorer/license/
69 sgo:sdDataset articles
70 rdf:type schema:ScholarlyArticle
71 N11286db902f445fea3af56387f27ec13 rdf:first sg:person.0750105001.98
72 rdf:rest Ned4cb6fc2fd74210b28defac42781a79
73 N1384a9a625554b6ea4b197ca06cf6c88 schema:name dimensions_id
74 schema:value pub.1025873521
75 rdf:type schema:PropertyValue
76 N166bd9b7a2364c4fb8e4d7e1b015f9ae schema:name readcube_id
77 schema:value 7b439e730321861869fefaaf8d770228eaa46844f7b7a07bb1718c1229821cb7
78 rdf:type schema:PropertyValue
79 N1f35f104a0c145f88fb383736a76aec1 schema:name Department of Experimental Cancer Research, Asta Pharma AG, P. O. Box 14 01 29, D-4800, Bielefeld 14, FRG
80 rdf:type schema:Organization
81 N3410a323bab14d1ebc9809362fc19ff7 schema:name doi
82 schema:value 10.1007/bf00204986
83 rdf:type schema:PropertyValue
84 N3eaebb9ab3c74ace93996a478e03030f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Mice, Nude
86 rdf:type schema:DefinedTerm
87 N48d9ca0ffd7549e5bac3dc17e98dceaa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Immunization, Passive
89 rdf:type schema:DefinedTerm
90 N53f2cd6aecdf490886fe7a7d00e90290 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Immunity, Innate
92 rdf:type schema:DefinedTerm
93 N58234785e4d548a98d76a8749910389a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Mice
95 rdf:type schema:DefinedTerm
96 N5cfad2edadc94dca92292e170fa24469 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Rats, Inbred Strains
98 rdf:type schema:DefinedTerm
99 N66d99ab536154b649b23c8baa0857fef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Rats
101 rdf:type schema:DefinedTerm
102 N6a8f8f0074734b3e9078e76206d9f724 schema:name nlm_unique_id
103 schema:value 8605732
104 rdf:type schema:PropertyValue
105 N72823be6efaf46bb9350166ddc02d7e6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Drug Administration Schedule
107 rdf:type schema:DefinedTerm
108 N83d31261c3134ce7a9ca077f1e24793e rdf:first sg:person.01340535776.53
109 rdf:rest Ne94288ff2bd64e56b79c676746772fd9
110 N86b38f0618334fef8652fde06c1d9623 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Adjuvants, Immunologic
112 rdf:type schema:DefinedTerm
113 N8b58ed1d02574eb49952fa1616ecedd2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Cyclophosphamide
115 rdf:type schema:DefinedTerm
116 N8e719ca41bbf4c949b908ac7379d37d7 schema:name pubmed_id
117 schema:value 2924329
118 rdf:type schema:PropertyValue
119 N8fdedbb5b45c4c5db09c8c85f15b65ab schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Antigens, Neoplasm
121 rdf:type schema:DefinedTerm
122 Na25d9468dc8d4fa4aed0570ca6d9a975 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Male
124 rdf:type schema:DefinedTerm
125 Na413d4831e1a4cf9826616cd4860f16b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Female
127 rdf:type schema:DefinedTerm
128 Naaf0cf61def34f678979fae49065694f schema:name Department of Experimental Cancer Research, Asta Pharma AG, P. O. Box 14 01 29, D-4800, Bielefeld 14, FRG
129 rdf:type schema:Organization
130 Naf05fce02f9c49f7a73b84b438ed74d5 schema:name Department of Experimental Cancer Research, Asta Pharma AG, P. O. Box 14 01 29, D-4800, Bielefeld 14, FRG
131 rdf:type schema:Organization
132 Nb9533c5a86df47149155c7a5b2e9368b schema:name Department of Experimental Cancer Research, Asta Pharma AG, P. O. Box 14 01 29, D-4800, Bielefeld 14, FRG
133 rdf:type schema:Organization
134 Nbdf7fb01b96c48e2854d10a9ba56fdf4 schema:volumeNumber 28
135 rdf:type schema:PublicationVolume
136 Nc193b22832f44093b30dfe972d2f58ad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Mice, Inbred BALB C
138 rdf:type schema:DefinedTerm
139 Nc9fa4ce529064e1d9d7beb2bd085e039 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Leukemia, Experimental
141 rdf:type schema:DefinedTerm
142 Nd96152414a004be1b20a56706f6cecb7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Animals
144 rdf:type schema:DefinedTerm
145 Ndfad057bf444412ab29ea54426d9b8ae schema:name Springer Nature - SN SciGraph project
146 rdf:type schema:Organization
147 Ne94288ff2bd64e56b79c676746772fd9 rdf:first sg:person.0633453775.54
148 rdf:rest N11286db902f445fea3af56387f27ec13
149 Neb4f749381374e3fad083957ca96ec1e schema:issueNumber 3
150 rdf:type schema:PublicationIssue
151 Ned4cb6fc2fd74210b28defac42781a79 rdf:first sg:person.01023655171.21
152 rdf:rest rdf:nil
153 Nf18f853334fc4f558a691a866754e39d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Clone Cells
155 rdf:type schema:DefinedTerm
156 Nff365029f1de431dad39696ac64524b8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Neoplasm Transplantation
158 rdf:type schema:DefinedTerm
159 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
160 schema:name Medical and Health Sciences
161 rdf:type schema:DefinedTerm
162 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
163 schema:name Immunology
164 rdf:type schema:DefinedTerm
165 sg:journal.1096240 schema:issn 0340-7004
166 1432-0851
167 schema:name Cancer Immunology, Immunotherapy
168 rdf:type schema:Periodical
169 sg:person.01023655171.21 schema:affiliation Naf05fce02f9c49f7a73b84b438ed74d5
170 schema:familyName Hilgard
171 schema:givenName Peter
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023655171.21
173 rdf:type schema:Person
174 sg:person.01340535776.53 schema:affiliation N1f35f104a0c145f88fb383736a76aec1
175 schema:familyName Reissmann
176 schema:givenName Thomas
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340535776.53
178 rdf:type schema:Person
179 sg:person.0633453775.54 schema:affiliation Naaf0cf61def34f678979fae49065694f
180 schema:familyName Voegeli
181 schema:givenName Rainer
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0633453775.54
183 rdf:type schema:Person
184 sg:person.0750105001.98 schema:affiliation Nb9533c5a86df47149155c7a5b2e9368b
185 schema:familyName Pohl
186 schema:givenName Jörg
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750105001.98
188 rdf:type schema:Person
189 sg:pub.10.1007/bf00199832 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053466732
190 https://doi.org/10.1007/bf00199832
191 rdf:type schema:CreativeWork
192 sg:pub.10.1007/bf00205549 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046560457
193 https://doi.org/10.1007/bf00205549
194 rdf:type schema:CreativeWork
195 sg:pub.10.1007/bf00205685 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031449860
196 https://doi.org/10.1007/bf00205685
197 rdf:type schema:CreativeWork
198 sg:pub.10.1007/bf01631649 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000151847
199 https://doi.org/10.1007/bf01631649
200 rdf:type schema:CreativeWork
201 sg:pub.10.1038/262077a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053098476
202 https://doi.org/10.1038/262077a0
203 rdf:type schema:CreativeWork
204 sg:pub.10.1038/271663a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041761092
205 https://doi.org/10.1038/271663a0
206 rdf:type schema:CreativeWork
207 https://app.dimensions.ai/details/publication/pub.1079465053 schema:CreativeWork
208 https://app.dimensions.ai/details/publication/pub.1079745935 schema:CreativeWork
209 https://app.dimensions.ai/details/publication/pub.1079848326 schema:CreativeWork
210 https://app.dimensions.ai/details/publication/pub.1079909305 schema:CreativeWork
211 https://app.dimensions.ai/details/publication/pub.1080245159 schema:CreativeWork
212 https://app.dimensions.ai/details/publication/pub.1081599010 schema:CreativeWork
213 https://app.dimensions.ai/details/publication/pub.1081632263 schema:CreativeWork
214 https://app.dimensions.ai/details/publication/pub.1082078324 schema:CreativeWork
215 https://app.dimensions.ai/details/publication/pub.1082165067 schema:CreativeWork
216 https://app.dimensions.ai/details/publication/pub.1082270364 schema:CreativeWork
217 https://doi.org/10.1016/0022-1759(83)90303-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053705634
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1016/0192-0561(85)90016-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009463786
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1016/0192-0561(86)90098-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026508026
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1016/s0065-230x(08)60846-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022578868
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1016/s0065-2776(08)60685-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005456489
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1084/jem.155.1.276 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012689937
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1093/jnci/18.6.769 schema:sameAs https://app.dimensions.ai/details/publication/pub.1075788095
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1093/jnci/76.4.745 schema:sameAs https://app.dimensions.ai/details/publication/pub.1079760047
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1093/jnci/77.6.1255 schema:sameAs https://app.dimensions.ai/details/publication/pub.1079781898
234 rdf:type schema:CreativeWork
 




Preview window. Press ESC to close (or click here)


...